EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A retrospective single-center pilot study of the genetic background of the transplanted kidney

Anna Novotna, Klara Horackova iD, Jana Soukupova, Petra Zemankova, Petr Nehasil, Pavel Just, Ludek Voska, Petra Kleiblova, Silvie Rajnochova Bloudickova iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0316192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Anna Novotna und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Hauptthemen laut MEDLINE: Kidney Transplantation, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky, Univerzita Karlova v Praze, Ministerstvo Školství, Mládeže a Tělovýchovy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Renal cell carcinoma (RCC) is one of the most prevalent cancers in kidney transplant recipients (KTR). The hereditary background of RCC in native kidneys has been determined, implicating its clinical importance. Materials and methods This retrospective single-center pilot study aimed to identify a potential genetic predisposition to RCC of the transplanted kidney and outcome in KTR who underwent single kidney transplantation between January 2000 and December 2020 and manifested RCC of the transplanted kidney. Next-generation sequencing (NGS) based germline genetic analysis from peripheral blood-derived genomic DNA (gDNA) was performed in both the recipient and donor using a gene panel targeting 226 cancer predisposition genes.

Results

The calculated incidence of RCC of the transplanted kidney among 4146 KTR was 0.43%. In fifteen KTR and donors, NGS was performed. The mean KTR age at transplantation and the diagnosis of RCC was 50.3 years (median 54; 5–67 years) and 66 years (median 66; 24–79 years), respectively. The mean donor age at transplantation and graft age at RCC diagnosis was 39.7 years (median 42; 7–68 years) and 50.2 years (median 46; 20–83 years), respectively. The mean follow-up after RCC diagnosis was 47 months (median 39.1; 0–112 months). Papillary RCC was the most prevalent (n = 8), followed by clear cell RCC (n = 6) and unspecified RCC (n = 1). Thirteen RCCs were low-stage (pT1a/b) diseases, one was pT3, and one was of unknown stage. Most RCC was higher graded. No germline pathogenic cancer-predisposition variant was found in either KTR or donors except for several variants of uncertain significance.

Conclusion

RCC of the transplanted kidney is very rare. Germline cancer-predisposition testing has identified several variants of uncertain significance, but no germline genetic predisposition to graft RCC in KTR. Further research is needed to assess the clinical relevance of genetic testing for cancer risk in KTR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCarcinoma, Renal CellKidney NeoplasmsHumansMiddle AgedPilot ProjectsRetrospective StudiesAdultFemaleMaleAgedChildAdolescentGenetic Predisposition to DiseaseYoung AdultHigh-Throughput Nucleotide SequencingChild, PreschoolAged, 80 and overTissue Donors

Autor:innen und Institutionen

  • Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Prague, Czech Republic.
  • Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University and General University Hospital in Prague, Prague, Czech Republic.

ORCID-Profile: Klara Horackova, Silvie Rajnochova Bloudickova

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky
  • Univerzita Karlova v Praze
  • Ministerstvo Školství, Mládeže a Tělovýchovy

Zitieren

APA

Novotna, A., Horackova, K., Soukupova, J., Zemankova, P., Nehasil, P., Just, P., Voska, L., Kleiblova, P., & Rajnochova Bloudickova, S. (2025). A retrospective single-center pilot study of the genetic background of the transplanted kidney. PLOS ONE. https://doi.org/10.1371/journal.pone.0316192

Vancouver

Novotna A, Horackova K, Soukupova J, Zemankova P, Nehasil P, Just P, et al. A retrospective single-center pilot study of the genetic background of the transplanted kidney. PLOS ONE. 2025. doi:10.1371/journal.pone.0316192

BibTeX
@article{Novotna2025,
  author = {Novotna, Anna and Horackova, Klara and Soukupova, Jana and Zemankova, Petra and Nehasil, Petr and Just, Pavel and Voska, Ludek and Kleiblova, Petra and Rajnochova Bloudickova, Silvie},
  title = {A retrospective single-center pilot study of the genetic background of the transplanted kidney},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0316192}
}
Kostenlos starten →